Clinical Trial Update: Canakinumab for Treatment of Adult-onset Still's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update on canakinumab for adult-onset Still's disease (terminated; results posted).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adult-onset Still Disease

Drugs mentioned

• Canakinumab (canakinumab)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Adult-Onset Still´s Disease | Phase 2 | Status: TERMINATED | Results posted: 2020-08-07